Brief: Lakeshore Biopharma Dave Chenn Resigned As Chairman
12/05/2025 12:24
May 12 (Reuters) - LAKESHORE BIOPHARMA: DAVE CHENN RESIGNED AS CHAIRMAN LAKESHORE BIOPHARMA: PIERSON YUE PAN APPOINTED AS CHAIRMAN Source text: [ID:n0001213900-25-041709] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on LakeShore Biopharma Co
See all newsBrief: LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
Brief: LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
Brief: Lakeshore Biopharma Announces Receipt Of A Preliminary Non-Binding Proposal To Acquire The Company
Brief: Lakeshore Biopharma Expects 2026 Revenue To Be Between RMB550 Million And RMB650 Million
Brief: Lakeshore Biopharma Announces Us$15 Million Private Placement Financing